The global progressive multifocal leukoencephalopathy (PML) treatment market is projected to experience stable growth over the next decade, reaching a value of USD 1,773.97 million by 2033, growing at a CAGR of 3% from 2023 to 2033. Currently valued at USD 1,320 million in 2023, the market has witnessed steady progress, registering a CAGR of …